METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner
활용도 Analysis
논문 Analysis
연구자 Analysis
'
METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner' 의 참고문헌
microRNA-129-5p suppresses Adriamycin resistance in breast cancer by targeting SOX2
miR-381 overcomes cisplatin resistance in breast cancer by targeting MDR1
miR-302a/b/c/d cooperatively inhibit BCRP expression to increase drug sensitivity in breast cancer cells
miR-221/222 promotes S-phase entry and cellular migration in control of basal-like breast cancer
miR-221/222 promote tumor growth and suppress apoptosis by targeting lncRNA GAS5 in breast cancer
miR-221 targets QKI to enhance the tumorigenic capacity of human colorectal cancer stem cells
miR-221 and miR-222 synergistically regulate hepatocyte growth factor activator inhibitor type 1 to promote cell proliferation and migration in gastric cancer
m(6)A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR1914-3p-YAP axis to induce NSCLC drug resistance and metastasis
Update on the regulation of HIPK1, HIPK2 and HIPK3 protein kinases by microRNAs
The significance of expression of autophagy-related gene Beclin, Bcl-2, and Bax in breast cancer tissues
The role of oncomirs in the pathogenesis and treatment of breast cancer
The investigation of miR-221-3p and PAK1 gene expressions in breast cancer cell lines
Role of ABC-cassette transporters(MDR1, MRP1, BCRP)in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer
Prognostic and biological significance of microRNA-221 in breast cancer
Predicting and overcoming chemotherapeutic resistance in breast cancer
Plasma miR-221 as a predictive biomarker for chemoresistance in breast cancer patients who previously received neoadjuvant chemotherapy
Natural product toosendanin reverses the resistance of human breast cancer cells to adriamycin as a novel PI3K inhibitor
N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2
N(6)-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer
N(6)-methyladenosine mediates the cellular proliferation and apoptosis via microRNAs in arsenite-transformed cells
MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway
METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner
HIPK2 sustains apoptotic response by phosphorylating Che1/AATF and promoting its degradation
HIPK2 downregulates vimentin and inhibits breast cancer cell invasion
Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Effects of adenovirus vectors mediated human lactoferrin cDNA on mice bearing EMT6 breast carcinoma
Doxorubicin-loaded nanoparticles : new advances in breast cancer therapy
Discovering Che-1/AATF : a new attractive target for cancer therapy
Cross-roads to drug resistance and metastasis in breast cancer : miRNAs regulatory function and biomarker capability
Co-expression of HIF1alpha, MDR1 and LAPTM4B in peripheral blood of solid tumors
Classification, treatment strategy, and associated drug resistance in breast cancer
Che-1 activates XIAP expression in response to DNA damage
Autophagy and doxorubicin resistance in cancer
Apoptosis-antagonizing transcription factor(AATF)gene silencing : role in induction of apoptosis and down-regulation of estrogen receptor in breast cancer cells
Analysis of miRNA-221 expression level in tumors and marginal biopsies from patients with breast cancer(cross-sectional observational study)
4-Hydroxybenzoic acid(4-HBA)enhances the sensitivity of human breast cancer cells to adriamycin as a specific HDAC6 inhibitor by promoting HIPK2/p53 pathway
'
METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner'
의 유사주제(
) 논문